Correlation Between Biofrontera and Petros Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Biofrontera and Petros Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofrontera and Petros Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biofrontera and Petros Pharmaceuticals, you can compare the effects of market volatilities on Biofrontera and Petros Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofrontera with a short position of Petros Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofrontera and Petros Pharmaceuticals.

Diversification Opportunities for Biofrontera and Petros Pharmaceuticals

0.05

Correlation Coefficient

Biofrontera  Petros Pharmaceuticals

Significant diversification

The 3 months correlation between Biofrontera and Petros is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Biofrontera and Petros Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Petros Pharmaceuticals and Biofrontera is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofrontera are associated (or correlated) with Petros Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Petros Pharmaceuticals has no effect on the direction of Biofrontera i.e., Biofrontera and Petros Pharmaceuticals go up and down completely randomly.

Pair Corralation between Biofrontera and Petros Pharmaceuticals

Given the investment horizon of 90 days Biofrontera is expected to generate 0.3 times more return on investment than Petros Pharmaceuticals. However, Biofrontera is 3.37 times less risky than Petros Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Petros Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest  90.00  in Biofrontera on November 29, 2024 and sell it today you would earn a total of  12.00  from holding Biofrontera or generate 13.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Biofrontera  vs.  Petros Pharmaceuticals

Biofrontera

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Biofrontera are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly inconsistent basic indicators, Biofrontera demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Petros Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Petros Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Biofrontera and Petros Pharmaceuticals

The main advantage of trading using opposite Biofrontera and Petros Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofrontera position performs unexpectedly, Petros Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Petros Pharmaceuticals will offset losses from the drop in Petros Pharmaceuticals' long position.

The idea behind Biofrontera and Petros Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.